[
  {
    "id": "1761757964783",
    "projectId": "P-1761243049041",
    "name": "test 1",
    "data": {
      "Demographics": [],
      "BACKGROUND": [],
      "DETAILED REVIEW OF MESSAGING": [],
      "COMPREHENSIVE RANKING EXERCISE": [],
      "GPF MESSAGE EVAL": [],
      "Misc.": []
    },
    "guideMap": {
      "bySheet": {}
    },
    "quotes": {},
    "savedAt": "2025-10-29T18:48:30.157Z",
    "savedBy": "You",
    "context": {},
    "transcripts": [
      {
        "id": "T-1761251220504",
        "sourceTranscriptId": "T-1761251220504",
        "respno": "R01",
        "addedAt": "2025-10-29T18:33:20.102Z",
        "filename": "cleaned_1761251233286_transcript example 3.docx",
        "originalPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\original_1761251233287_transcript example 3.docx",
        "cleanedPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\cleaned_1761251233286_transcript example 3.docx",
        "originalFilename": "transcript example 3.docx",
        "cleanedFilename": "cleaned_1761251233286_transcript example 3.docx",
        "isCleaned": true,
        "demographics": {
          "Respondent ID": "R01",
          "respno": "R01"
        }
      }
    ],
    "columnSchema": {
      "Demographics": [
        "Respondent ID",
        "Interview Date",
        "Interview Time"
      ],
      "BACKGROUND": [
        "Respondent ID",
        "Introduction",
        "Specialty",
        "Years in Practice",
        "Practice Setting",
        "SMA Patients Under Care",
        "Primary Role in Managing SMA Patients",
        "Factors for Treatment Decision",
        "Typical Approach to Treating SMA",
        "Discussion on Treatment Switching",
        "Biggest Challenges for Patients",
        "Access Challenges for Specific Treatments",
        "Addressing Challenges",
        "Reliance on Support Programs",
        "Unmet Needs in Insurance Support"
      ],
      "DETAILED REVIEW OF MESSAGING": [
        "Respondent ID",
        "Overall Reaction to Statements",
        "Surprising Information",
        "Ranking of Statements",
        "Reason for Ranking",
        "Impact on Manufacturer Perception",
        "Alignment with Current Understanding",
        "New Learnings",
        "Individual Statement Review",
        "Main Takeaway"
      ],
      "COMPREHENSIVE RANKING EXERCISE": [
        "Respondent ID",
        "Compelling Story Statements",
        "Message Order Explanation",
        "Most Important Messages",
        "Perception Changes",
        "Access Process Impact",
        "Likelihood to Consider Evrysdi",
        "Missing Elements",
        "New Learnings"
      ],
      "GPF MESSAGE EVAL": [
        "Respondent ID",
        "Overall Reaction to Statements",
        "Surprising Information",
        "Ranking of Statements",
        "Reason for Ranking",
        "Impact on Manufacturer Perception",
        "Alignment with Current Understanding",
        "New Learnings",
        "Individual Statement Review",
        "Main Takeaway",
        "Familiarity with GPF",
        "Pursuit of GPF",
        "Flexibility of GPF",
        "Awareness of Limited Resource"
      ],
      "Misc.": [
        "Respondent ID",
        "Final Comments",
        "Additional Notes"
      ]
    }
  },
  {
    "id": "1761748119990",
    "projectId": "P-1761587638538",
    "name": "test",
    "data": {
      "Demographics": [
        {
          "Respondent ID": "",
          "Interview Date": "",
          "Interview Time": ""
        }
      ],
      "BACKGROUND": [
        {
          "Respondent ID": "",
          "Living Situation": "",
          "Current Health Description": "",
          "Health Management Involvement": "",
          "Receiving Treatment": "",
          "Treatment Duration": "",
          "Treatment Decision Factors": "",
          "Treatment Pursuit Timing": "",
          "Treatment Pursuit Reasons": "",
          "Treatment Experience": "",
          "Discontinuation Consideration": "",
          "Switching Consideration": "",
          "Switching Concerns": "",
          "Unsatisfactory Treatment Response": "",
          "Access Issues Experience": "",
          "Access Challenges": "",
          "Challenges Resolution": "",
          "Resolution Success": "",
          "Resolution Improvement": "",
          "Past Treatment Experience": "",
          "Past Treatment Access Challenges": "",
          "Past Challenges Resolution": "",
          "Past Resolution Success": "",
          "Past Resolution Improvement": "",
          "Impressions of Untaken Treatment": "",
          "Untaken Treatment Consideration": "",
          "Untaken Treatment Access Challenges": "",
          "Untaken Challenges Resolution": "",
          "Untaken Resolution Success": "",
          "Untaken Resolution Improvement": "",
          "Awareness of Developmental Treatments": "",
          "Knowledge of Treatments": "",
          "Interest in Treatments": "",
          "Treatment Consideration Factors": "",
          "Community Involvement Level": "",
          "Support Group Membership": "",
          "Information Sources": ""
        }
      ],
      "DETAILED REVIEW OF MESSAGING": [
        {
          "Respondent ID": "",
          "Overall Reaction": "",
          "Surprising Information": "",
          "Ranking": "",
          "Ranking Reasons": "",
          "Preferred Statement": "",
          "Least Preferred Statement": "",
          "Impact on Manufacturer Perception": "",
          "Alignment with Understanding": "",
          "New Learnings": "",
          "Individual Statement Feedback": "",
          "Attention-Catching Phrases": "",
          "Language Impact": "",
          "Clarity Concerns": "",
          "Motivation Level": "",
          "Differentiation Level": "",
          "Believability": "",
          "Improvement Suggestions": "",
          "Main Takeaway": ""
        }
      ],
      "COMPREHENSIVE RANKING EXERCISE": [
        {
          "Respondent ID": "",
          "Compelling Statements": "",
          "Statement Selection Process": "",
          "Statement Ordering": "",
          "Most Important Statements": "",
          "Perception Changes": "",
          "Evrysdi Comparison": "",
          "Access Process Perception": "",
          "Likelihood of Switching": "",
          "Likelihood Scale Comparison": "",
          "Differentiation Enhancements": "",
          "New Learnings": ""
        }
      ],
      "Misc.": [
        {
          "Respondent ID": "",
          "Final Comments": "",
          "Additional Notes": ""
        }
      ]
    },
    "guideMap": {
      "bySheet": {}
    },
    "quotes": {},
    "savedAt": "2025-10-29T14:28:39.990Z",
    "savedBy": "You"
  },
  {
    "id": "1761251648433",
    "projectId": "P-1761243049041",
    "name": "test CA 2",
    "data": {
      "Demographics": [
        {
          "Respondent ID": "R01",
          "Interview Date": "Oct 28, 2025",
          "Interview Time": "5:00 PM",
          "respno": "R01",
          "transcriptId": "T-1761763093840"
        }
      ],
      "BACKGROUND": [
        {
          "Respondent ID": "R01",
          "Living Situation": "",
          "Free Time Activities": "",
          "Journey with SMA": "",
          "Current Health Description": "",
          "HCPs for SMA Care": "The respondent is a professor in pediatric neurology at an academic medical center, where they have been working for over twenty years. They manage a dedicated MDA clinic and have seen approximately 30 patients with SMA throughout their career. Currently, they regularly see 13 patients, with 80% being under 18 and the oldest patient being 22 years old. The respondent's approach to treating SMA involves gene therapy for younger patients and intrathecal injections or pills for others, with no patients on double therapy yet.",
          "Reasons for Not Seeing HCPs": "",
          "Current SMA Management": "The respondent manages SMA by using gene therapy for patients younger than two years old, before they can receive SPINRAZA. For other patients, they use intrathecal injections like SPINRAZA or a pill form of medication. They have five patients on SPINRAZA and the rest on the pill. They have not yet started any patients on double therapy, although they are considering it for one patient who showed muscle weakness after gene therapy.",
          "Number of HCPs": "",
          "HCP Involvement in Treatment Decisions": "",
          "Primary SMA Doctor": "",
          "Others Involved in Health Decisions": "",
          "Support System Involvement": "",
          "Comfort in Making Treatment Decisions": "",
          "Health Goals - Short-term": "",
          "Health Goals - Long-term": "",
          "Personal Aspirations": "",
          "respno": "R01"
        }
      ],
      "CURRENT PERCEPTIONS & ATTITUDES": [
        {
          "Respondent ID": "R01",
          "Treatments Awareness": "",
          "Evrysdi Experience": "",
          "Spinraza Experience": "",
          "Zolgensma Experience": "",
          "Discontinued Treatment Experience": "",
          "Discontinued Treatment Benefits": "",
          "Discontinued Treatment Drawbacks": "",
          "Discontinuation Reason": "",
          "Life Changes Impact": "",
          "Insurance Coverage Impact": "The respondent notes that insurance access to SMA therapies has improved significantly, with approvals now happening much quicker than before. However, combinations of therapies still present challenges and require justification. They are currently appealing for one patient, documenting motor function and symptoms to support the case. The manufacturer assists with paperwork and the appeal process, which the respondent finds helpful.",
          "Restarting Consideration": "",
          "Treatment Impressions": "",
          "Information Source": "",
          "Consideration Factors": "",
          "Developmental Treatments Awareness": "",
          "Developmental Treatments Impressions": "",
          "Candidate Consideration": "",
          "Future Treatment Consideration": "",
          "Consideration Drivers": "",
          "Consideration Hesitations": "",
          "Anti-myostatins Awareness": "",
          "Anti-myostatins Brands": "",
          "respno": "R01"
        }
      ],
      "BARRIERS TO TREATMENT & UNMET NEEDS": [
        {
          "Respondent ID": "R01",
          "Reasons for Not on Treatment": "",
          "Manageable Severity Impact": "",
          "Consideration Drivers": "",
          "Muscle Loss Impact": "",
          "Symptom Tracking Frequency": "",
          "Symptom Tracking Method": "",
          "Symptom Tracking Discussion": "",
          "Emotional Factors Impact": "",
          "Practical Factors Impact": "",
          "Clinical Factors Impact": "",
          "Treatment Benefit Requirement": "",
          "Treatment Benefit Discussion": "",
          "Financial Barriers Impact": "",
          "Financial Challenges": "",
          "Access Challenges": "",
          "Specialized Care Availability": "",
          "HCP Trust": "",
          "Support System Gaps": "",
          "Unmet Needs": "",
          "respno": "R01"
        }
      ],
      "MOTIVATIONS & FUTURE CONSIDERATION": [
        {
          "Respondent ID": "R01",
          "Future Treatment Likelihood": "",
          "Consideration Influences": "",
          "Consideration Situations": "",
          "Consideration Drivers": "",
          "Consideration Hesitations": "",
          "Improvement Expectations": "",
          "Influential Decision Makers": "",
          "Decision Maker Involvement": "",
          "Decision Confidence Factors": "",
          "respno": "R01"
        }
      ],
      "COMMUNITY ENGAGEMENT & INFO SOURCES": [
        {
          "Respondent ID": "R01",
          "Community Connection": "",
          "Community Participation": "",
          "Community Involvement Reasons": "",
          "Information Sources": "",
          "Trusted Sources": "",
          "Distrusted Sources": "",
          "New Information Awareness": "",
          "Information Preferences": "",
          "Preferred Information Format": "",
          "Facilitation Suggestions": "",
          "respno": "R01"
        }
      ],
      "Misc.": [
        {
          "Respondent ID": "R01",
          "Final Comments": "",
          "Additional Notes": "",
          "respno": "R01"
        }
      ]
    },
    "guideMap": {
      "bySheet": {}
    },
    "quotes": {},
    "savedAt": "2025-10-29T18:39:39.914Z",
    "savedBy": "You",
    "context": {},
    "transcripts": [
      {
        "id": "T-1761244346544",
        "sourceTranscriptId": "T-1761244346544",
        "respno": "R03",
        "addedAt": "2025-10-23T20:44:50.612Z",
        "filename": "cleaned_1761244424155_Treatment Naive_ENGLISH (UNITED STATES)_MT.docx",
        "originalPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\original_1761244424156_Treatment Naive_ENGLISH (UNITED STATES)_MT.docx",
        "cleanedPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\cleaned_1761244424155_Treatment Naive_ENGLISH (UNITED STATES)_MT.docx",
        "originalFilename": "Treatment Naive_ENGLISH (UNITED STATES)_MT.docx",
        "cleanedFilename": "cleaned_1761244424155_Treatment Naive_ENGLISH (UNITED STATES)_MT.docx",
        "isCleaned": true
      },
      {
        "id": "T-1761251220504",
        "sourceTranscriptId": "T-1761251220504",
        "respno": "R01",
        "addedAt": "2025-10-23T20:50:19.728Z",
        "filename": "cleaned_1761251233286_transcript example 3.docx",
        "originalPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\original_1761251233287_transcript example 3.docx",
        "cleanedPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\cleaned_1761251233286_transcript example 3.docx",
        "originalFilename": "transcript example 3.docx",
        "cleanedFilename": "cleaned_1761251233286_transcript example 3.docx",
        "isCleaned": true
      },
      {
        "id": "T-1761250872583",
        "sourceTranscriptId": "T-1761250872583",
        "respno": "R02",
        "addedAt": "2025-10-23T20:51:08.128Z",
        "filename": "cleaned_1761250900961_transcript example 2.docx",
        "originalPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\original_1761250900962_transcript example 2.docx",
        "cleanedPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\cleaned_1761250900961_transcript example 2.docx",
        "originalFilename": "transcript example 2.docx",
        "cleanedFilename": "cleaned_1761250900961_transcript example 2.docx",
        "isCleaned": true
      },
      {
        "id": "T-1761252705435",
        "sourceTranscriptId": "T-1761252705435",
        "respno": "R03",
        "addedAt": "2025-10-23T20:53:59.196Z",
        "filename": "cleaned_1761252772006_transcript example.docx",
        "originalPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\original_1761252772007_transcript example.docx",
        "cleanedPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\cleaned_1761252772006_transcript example.docx",
        "originalFilename": "transcript example.docx",
        "cleanedFilename": "cleaned_1761252772006_transcript example.docx",
        "isCleaned": true
      },
      {
        "id": "T-1761763093840",
        "sourceTranscriptId": "T-1761763093840",
        "respno": "R01",
        "addedAt": "2025-10-29T18:39:39.913Z",
        "filename": "cleaned_1761763146694_HCP 491135_ENGLISH (UNITED STATES)_MT.docx",
        "originalPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\original_1761763146696_HCP 491135_ENGLISH (UNITED STATES)_MT.docx",
        "cleanedPath": "C:\\Users\\LukeBorglin\\Desktop\\Apps\\JaiceDashboard_master\\server\\data\\uploads\\cleaned_1761763146694_HCP 491135_ENGLISH (UNITED STATES)_MT.docx",
        "originalFilename": "HCP 491135_ENGLISH (UNITED STATES)_MT.docx",
        "cleanedFilename": "cleaned_1761763146694_HCP 491135_ENGLISH (UNITED STATES)_MT.docx",
        "isCleaned": true
      }
    ],
    "columnSchema": {
      "Demographics": [
        "Respondent ID",
        "Interview Date",
        "Interview Time"
      ],
      "BACKGROUND": [
        "Respondent ID",
        "Living Situation",
        "Free Time Activities",
        "Journey with SMA",
        "Current Health Description",
        "HCPs for SMA Care",
        "Reasons for Not Seeing HCPs",
        "Current SMA Management",
        "Number of HCPs",
        "HCP Involvement in Treatment Decisions",
        "Primary SMA Doctor",
        "Others Involved in Health Decisions",
        "Support System Involvement",
        "Comfort in Making Treatment Decisions",
        "Health Goals - Short-term",
        "Health Goals - Long-term",
        "Personal Aspirations"
      ],
      "CURRENT PERCEPTIONS & ATTITUDES": [
        "Respondent ID",
        "Treatments Awareness",
        "Evrysdi Experience",
        "Spinraza Experience",
        "Zolgensma Experience",
        "Discontinued Treatment Experience",
        "Discontinued Treatment Benefits",
        "Discontinued Treatment Drawbacks",
        "Discontinuation Reason",
        "Life Changes Impact",
        "Insurance Coverage Impact",
        "Restarting Consideration",
        "Treatment Impressions",
        "Information Source",
        "Consideration Factors",
        "Developmental Treatments Awareness",
        "Developmental Treatments Impressions",
        "Candidate Consideration",
        "Future Treatment Consideration",
        "Consideration Drivers",
        "Consideration Hesitations",
        "Anti-myostatins Awareness",
        "Anti-myostatins Brands"
      ],
      "BARRIERS TO TREATMENT & UNMET NEEDS": [
        "Respondent ID",
        "Reasons for Not on Treatment",
        "Manageable Severity Impact",
        "Consideration Drivers",
        "Muscle Loss Impact",
        "Symptom Tracking Frequency",
        "Symptom Tracking Method",
        "Symptom Tracking Discussion",
        "Emotional Factors Impact",
        "Practical Factors Impact",
        "Clinical Factors Impact",
        "Treatment Benefit Requirement",
        "Treatment Benefit Discussion",
        "Financial Barriers Impact",
        "Financial Challenges",
        "Access Challenges",
        "Specialized Care Availability",
        "HCP Trust",
        "Support System Gaps",
        "Unmet Needs"
      ],
      "MOTIVATIONS & FUTURE CONSIDERATION": [
        "Respondent ID",
        "Future Treatment Likelihood",
        "Consideration Influences",
        "Consideration Situations",
        "Consideration Drivers",
        "Consideration Hesitations",
        "Improvement Expectations",
        "Influential Decision Makers",
        "Decision Maker Involvement",
        "Decision Confidence Factors"
      ],
      "COMMUNITY ENGAGEMENT & INFO SOURCES": [
        "Respondent ID",
        "Community Connection",
        "Community Participation",
        "Community Involvement Reasons",
        "Information Sources",
        "Trusted Sources",
        "Distrusted Sources",
        "New Information Awareness",
        "Information Preferences",
        "Preferred Information Format",
        "Facilitation Suggestions"
      ],
      "Misc.": [
        "Respondent ID",
        "Final Comments",
        "Additional Notes"
      ]
    },
    "verbatimQuotes": {
      "BACKGROUND": {
        "R01": {
          "Living Situation": {
            "quotes": [
              {
                "text": "Moderator: Can you tell me a little bit about yourself, if you live with anybody else, how you spend your days, just so I have a sense of who you are?\n\nRespondent: Sure. I live with my children and my husband, and we have two dogs. I work part-time for a local school, and I am enrolled in school to earn my bachelor's. I do all the other daily things in between.",
                "context": "This quote provides a direct description of the respondent's living situation, including her family members, pets, part-time job, and pursuit of a bachelor's degree, illustrating her busy and structured living environment."
              },
              {
                "text": "Moderator: How old are your kids?\n\nRespondent: I've got 19, 17, and 15.",
                "context": "This quote specifies the ages of the respondent's children, confirming the details about her family composition as mentioned in the key finding."
              },
              {
                "text": "Moderator: And amazing you're getting your bachelor's. What are you majoring in? Sorry, these are just nosy questions. They're not crucial, but it helps me get to know you a little bit.\n\nRespondent: You're good. I've got my associates in medical coding and billing and medical office admin, so I thought it'd be fun to get my bachelor's in human resource management.",
                "context": "This quote highlights the respondent's educational pursuits, specifically her goal to earn a bachelor's degree in human resource management, which is part of her structured living environment."
              }
            ],
            "transcriptType": "cleaned",
            "savedAt": "2025-10-23T20:55:49.249Z",
            "keyFinding": "The respondent lives with her husband and three children, aged 19, 17, and 15, along with two dogs. She balances her time between family responsibilities and her part-time job at a local school. Additionally, she is pursuing a bachelor's degree in human resource management, indicating a busy and structured living environment."
          }
        }
      },
      "COMMUNITY ENGAGEMENT & INFO SOURCES": {
        "R04": {
          "Community Connection": {
            "quotes": [
              {
                "text": "Moderator: Coming to the present, to what extent do you feel connected to any kind of SMA community now?\n\nRespondent: There's not really one here where I am. There was an MDA call center here for several years. I would visit them during the summer and hang out. I sort of became their mascot. Whenever they had an event in the area, I would get invited.",
                "context": "This quote shows that the respondent had some past involvement with the SMA community through the MDA call center but indicates that there is no active SMA community where he currently resides."
              },
              {
                "text": "Moderator: Do you have any connections to the SMA community, like online or in person?\n\nRespondent: Not particularly. I'm still friends with my counselor from camp on Facebook. We don't talk, but I see his life events.",
                "context": "This quote illustrates the respondent's limited connection to the SMA community, highlighting that his only ongoing connection is a passive one through Facebook with a former camp counselor."
              },
              {
                "text": "Moderator: Have you ever looked into or involved yourself in any of the online SMA stuff?\n\nRespondent: No. Not really. I find it more depressing than anything.\n\nModerator: Tell me about that. I'm really interested in that.\n\nRespondent: I've never particularly seen myself as disabled. It's just something that I live with. I find that mindset unique among the disabled community. Most of the time, they're like, \"I'm so crippled. I can't do this and I can't do that.\" Talking and whining about it isn't going to change anything. I've never found anything worth my time to be a part of as far as Facebook groups or anything.",
                "context": "This quote provides insight into the respondent's perception of online SMA communities, which he views as adopting a victim mentality, leading to his lack of engagement with them."
              }
            ],
            "transcriptType": "cleaned",
            "savedAt": "2025-10-29T15:54:49.402Z",
            "keyFinding": "The respondent has limited connection to the SMA community, both online and in person. He maintains some social connections from past experiences, such as MDA camp, but does not actively engage with SMA groups. His limited involvement is due to a preference for independence and a perception that online communities often adopt a victim mentality."
          }
        }
      }
    }
  },
  {
    "id": "1761237964523",
    "projectId": "P-1759172819869",
    "name": "aa CA",
    "data": {
      "Demographics": [
        {
          "Respondent ID": "R01",
          "Interview Date": "Oct 1, 2025",
          "Interview Time": "3:00 PM",
          "respno": "R01"
        }
      ],
      "BACKGROUND": [
        {
          "Respondent ID": "",
          "Living Situation": "",
          "Free Time Activities": "",
          "SMA Journey": "",
          "Current Health Description": "",
          "Seeing HCPs for SMA Care": "",
          "Reasons for Not Seeing HCPs": "",
          "Current SMA Management": "",
          "Number of HCPs Seen": "",
          "HCP Involvement in Treatment Decisions": "",
          "Primary SMA Doctor": "",
          "Others Involved in Health Decisions": "",
          "Extent of Involvement of Others": "",
          "Support System Lean On": "",
          "Comfort in Making Treatment Decisions": "",
          "Health Goals - Short-term": "",
          "Health Goals - Long-term": "",
          "Personal Aspirations": ""
        }
      ],
      "CURRENT PERCEPTIONS & ATTITUDES": [
        {
          "Respondent ID": "",
          "Awareness of Treatments": "",
          "Experience with Treatments": "",
          "Benefits of Discontinued Treatment": "",
          "Drawbacks of Discontinued Treatment": "",
          "Reasons for Discontinuation": "",
          "Life Changes Impacting Discontinuation": "",
          "Insurance Coverage Impact on Discontinuation": "",
          "Involvement in Decision to Stop Treatment": "",
          "Considerations for Restarting Treatment": "",
          "Impressions of Untaken Treatment": "",
          "Information Source for Untaken Treatment": "",
          "Consideration of Untaken Treatment": "",
          "HCP Discussion on Untaken Treatment": "",
          "Impact of HCP on Decision for Untaken Treatment": "",
          "Consideration of Future Treatments": "",
          "Impressions of In-development Treatments": "",
          "Consideration of In-development Treatments": "",
          "Good Candidate for In-development Treatments": ""
        }
      ],
      "BARRIERS TO TREATMENT & UNMET NEEDS": [
        {
          "Respondent ID": "",
          "Reasons for Not Being on Treatment": "",
          "Factors Driving Treatment Consideration": "",
          "Symptom Tracking Frequency": "",
          "Symptom Tracking Methods": "",
          "HCP Discussion on Treatment Need": "",
          "Emotional Factors Impacting Treatment Decision": "",
          "Practical/Logistical Factors Impacting Treatment Decision": "",
          "Clinical Factors Impacting Treatment Decision": "",
          "Treatment Benefit Requirement": "",
          "Financial/Access Barriers": "",
          "Challenges in Accessing Treatment": "",
          "Unmet Needs": "",
          "Most Important Unmet Need": ""
        }
      ],
      "MOTIVATIONS & FUTURE CONSIDERATION": [
        {
          "Respondent ID": "",
          "Likelihood of Future Treatment Consideration": "",
          "Factors Influencing Future Consideration": "",
          "Changes/Situations Increasing Likelihood": "",
          "Expectations from Treatment": "",
          "Influential Parties in Treatment Decision": "",
          "Confidence-building Factors for Treatment Decision": ""
        }
      ],
      "COMMUNITY ENGAGEMENT & INFO SOURCES": [
        {
          "Respondent ID": "",
          "Connection to SMA Community": "",
          "Participation in Support Groups": "",
          "Reasons for Non-involvement in Communities": "",
          "Information Sources on SMA": "",
          "Trusted Information Sources": "",
          "Untrusted Information Sources": "",
          "Discovery of New Treatments": "",
          "Preferred Information Format": "",
          "Improving Information Accessibility": ""
        }
      ],
      "Misc.": [
        {
          "Respondent ID": "",
          "Final Comments": "",
          "Additional Notes": ""
        }
      ]
    },
    "guideMap": {
      "bySheet": {}
    },
    "quotes": {},
    "savedAt": "2025-10-23T20:11:20.432Z",
    "savedBy": "You"
  }
]